Single-institution retrospective analysis for predictive factors of prostate cancer patients presenting with isolated or limited lymph node (LN) recurrence (1-3 lesions) on F-Ccholine PET-CT (CholPET) treated with SBRT between January 2010 and July 2015.
Single-institution retrospective analysis of consecutive prostate cancer patients after definitive primary treatment, without local recurrence, presenting with isolated or limited lymph node (LN) recurrence (1-3 lesions) on F-Ccholine PET-CT (CholPET) treated with SBRT between January 2010 and July 2015. Endpoints of interest are biochemical response rate (defined as a reduction by at least 10% of the initial PSA value), time to biochemical recurrence (TBR) (defined as the time interval from SBRT until second PSA rise), and time interval between SBRT and ADT start. Univariate analysis is used to identify prognostic factors.
Study Type
OBSERVATIONAL
Enrollment
25
Stereotactic Radiotherapy of lymphnode recurrence after prostatectomy +/- salvage radiotherapy
Juergen Curschmann
Zurich, Switzerland
time to biochemical recurrence
time interval from SBRT until second PSA rise
Time frame: 18 months
biochemical response rate
reduction by at least 10% of the initial PSA value
Time frame: 18 months
time interval between SBRT and ADT start
time interval between SBRT and ADT start
Time frame: 18 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.